Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel vs. Bupivacaine in laparoscopic colectomy
NCT05224089Phase 4Recruiting
- Sponsor
- Hartford Hospital
- Start
- Apr 2022
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Hartford Hospital. Primary endpoint: Highest Numerical Pain Scores at 3 days. Started Apr 2022; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05224089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05224089.